Alexandra Valenti
EMA Adopts Positive Opinion for Amgen’s Eculizumab Biosimilar Candidate BEKEMV®
Big Molecule Watch ·
Deal Watch: Henlius Licenses Rituximab and Trastuzumab Products to Abbott in Brazil
Big Molecule Watch ·
Purple Book Updates
Big Molecule Watch ·
Health Canada Approves Celltrion’s Adalimumab Biosimilar, YUFLYMA
Big Molecule Watch ·
Year in Review: Top Legal Developments of 2021 Impacting Biosimilars
Big Molecule Watch ·